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Platinum(IV) azido complexes undergo copper-free
click reactions with alkynes†
Nicola J. Farrer, *a Gitanjali Sharma,a Rachel Sayers,a Evyenia Shailib and
Peter J. Sadler b
We report our investigations into the ﬁrst examples of copper-free 1,3-dipolar cycloaddition (click) reac-
tions of electrophiles with a PtIV azido complex. The Pt-IV azido complex trans, trans, trans-
[PtIV(py)2(N3)2(OH)2] (1) was reactive towards dimethyl acetylenedicarboxylate (DMAD) (2), diethyl acetyl-
enedicarboxylate DEACD (3), N-[(1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethyloxycarbonyl]-1,8-diamino-
3,6-dioxaoctane (BCN) (11) and dibenzocyclooctyne-amine (DBCO) (12) resulting in formation of the
corresponding mono (a) and bis-substituted (b) complexes. Complexes of 2 undergo further reactions
between the Pt centre and the carbonyl group to form 2a’ and 2b’. This is not seen for the products of
the corresponding PtII azido complex trans-[Pt(py)2(N3)2] with acetylene 2. Novel complexes 2a’, 2b’, 11a
and 11b have been characterised by multinuclear NMR, IR and UV-vis spectroscopy and ESI-MS. These
reactions represent new synthetic routes to novel Pt(IV) complexes.
Introduction
Copper-free, azide–alkyne cycloaddition (“click”) reactions typi-
cally take place under mild conditions1,2 and provide a tanta-
lising route to modify ligands which are coordinated to a
metal centre. Since the conditions are well-tolerated by most
functional groups, the reaction can be used to introduce sensi-
tive functionality to complexes at a late stage. By avoiding the
use of cytotoxic copper salts it is particularly suitable for com-
plexes with eventual biological applications.3 Metal azido com-
plexes have a rich cycloaddition chemistry.4–6 A range of
d-block azido complexes, including those of Mn(I),7,8 Fe(III),9
Pd(II),10 Pt(II),10–15 Rh(III)16 and Au(I),17 have been reported to
undergo copper-free 1,3-dipolar cycloaddition or “click” reac-
tions with carbon–carbon and carbon-heteroatom functional
groups such as alkynes, isocyanides, isonitriles, nitriles,
carbon disulphides and isothiocyanates. Electron-deficient
alkynes such as dimethyl acetylenedicarboxylate (DMAD) and
diethyl acetylenedicarboxylate (DEACD) are relatively reactive:
Mo(II),16,18 Co(III),19 Fe(III)19,20 Ru(II),20–25 Pd(II)26–28 and Ta29
azido complexes all react with DMAD. Strain-promoted azide–
alkyne cycloadditions (SPAAC)30,31 are also an eﬀective method
for derivatising azido complexes.32 Click reactions between
metal azides and alkynes have been used to form Pt(II) hetero-
metallic arrays with Au(I)15 or Re/Rh;33 in the development of
new catalysts (Ru)21 and metalloenzyme inhibitors (Co(III),
Fe(III), Ni(II)),19 and to synthesise peptide bioconjugates (Au(I))
targeted to mitochondria.3 Azolato-bridged platinum com-
plexes show promising anti-cancer activity,34 and 1,2,3-triazole
ligands themselves have a wide-range of potential applications
including in biomedical35 and materials chemistry.36
Our interest in these reactions stems from our investi-
gations of photoactivatable platinum(IV) azido anti-cancer
complexes such as trans,trans,trans-[Pt(N3)2(OH)2(py)2]
(1, Scheme 1). Complex 1 is inert in the absence of light, but
shows potent cytotoxicity towards cancer cell lines upon
Scheme 1 Reaction of 1 with DMAD (2).
†Electronic supplementary information (ESI) available: Synthesis and character-
isation of Pt(I)I complexes, UV-vis, IR spectra, ESI-MS/MS. See DOI: 10.1039/
c7dt04183g
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irradiation with visible light.37 The mechanism of cell death
may be due to the formation of a number of diﬀerent species
including azido radicals, nitrenes and singlet oxygen,38,39 and
it is not clear whether both azido groups are necessary for the
photocytotoxic eﬀect. The synthetic route to these complexes
involves oxidation from PtII to PtIV with H2O2, a step which is
incompatible with a number of sensitive functional groups.
The capacity for derivatising one (or both) azido groups on a
PtIV centre through click chemistry therefore provides a route
to a wide array of functionality, and the reaction itself is bio-
logically compatible. It can be used to produce PtIV mono
azido complexes, a relatively unexplored class of compounds.
Whilst there are reports of PtII azido complexes undergoing
click reactions, there are none for PtIV systems, which are
anticipated to react significantly more slowly.
We report the results of our investigation of the reactions of
trans-[PtII(N3)2(py)2] and trans,trans,trans-[Pt
IV(N3)2(OH)2(py)2]
(1) with a range of internal and terminal alkynes (Fig. 1)
including (to the best of our knowledge) the first cycloaddition
reactions of a PtIV azido complex.
Results and discussion
We have previously reported a number of cis- and trans-PtIV
azido complexes of the form [Pt(N3)2(R)2(amine1)(amine2)2]
(where R = OH, OAc);40–42 complex 1 was chosen for cyclo-
addition investigations since it is readily synthesisable on a
large scale, displays good solubility in water and a range of
organic solvents and possesses convenient NMR spectroscopic
handles. Initial experiments with the PtII precursor complex
trans-[Pt(py)2(N3)2] indicated reactivity towards DMAD and
DEACD which encouraged us to investigate the reactivity of
complex 1.
Preparation of the PtII and PtIV azido complexes
The PtII and PtIV azido complexes were synthesised as pre-
viously described.37 All reactions and manipulations were
carried out so as to avoid unneccessary exposure to light.
Reactivity of trans-[PtII(N3)(py)2] and 1 towards alkynes
PtII azide complexes are known to adopt various bonding
modes and may also undergo a range of reactions as an
alternative to cycloaddition. Ligand substitution – for example,
substitution of an azide for an alkyne – instead of the antici-
pated cycloaddition has been reported for the complex cis-
[Pt(N3)2(PPh3)2] under microwave irradiation with HCuCR (R =
Ph, p-MeC6H4) at 100 °C.
43 In the reaction of [Pd(PPh3)2(N3)2]
with DMAD (the PtII derivative has not been investigated), a tri-
azole-bridged dimer was obtained, which was recrystallised in
the presence of PPh3 to give the bis substituted species
[Pd(PPh3)2(triazole)2].
26 In light of this product diversity, we con-
sidered a number of possible products in our investigations.
Furthermore, for several of the alkynes further reactivity
following triazole formation was possible, due to the presence
of reactive ligand-based groups. We also considered the possi-
bility of N1–N2 rearrangement of the resulting triazole: several
ruthenium azides have reacted with DMAD to produce N2-tri-
azole species,21,24,32,44 as confirmed by X-ray crystallography,
however, no literature examples of monodentate PtII/PtIV tri-
azoles could be found for us to draw comparisons with; for
those PtII triazoles with chelating groups on the triazole ligand
both N1 and N2 coordination has been previously observed,
depending on the influence of the chelating group.45
The PtII complex trans-[Pt(N3)2(py)2] reacted with DMAD (2)
in MeOH (35 °C) to give the mono (trans-[Pt(C6H6N3O4)(N3)
(py)2]) and bis (trans-[Pt(C6H6N3O4)2(py)2]) substituted com-
plexes in which both ester groups remained intact (ESI†). The
195Pt NMR resonance of the mono substituted complex trans-
[Pt(C6H6N3O4)(N3)(py)2] was seen at −2219 ppm (d3-MeCN),
approximately half-way between the starting material trans-
[Pt(N3)2(py)2] (−2122 ppm, d6-acetone)37 and the bis triazole
complex trans-[Pt(C6H6N3O4)2(py)2] (−2331 ppm, d6-acetone).
The 1H NMR spectrum for the mono-substituted complex
showed only one OMe environment, and no nOe correlation
was observed between the pyridine protons and the OMe
group. The 14N NMR spectrum of the bis substituted PtII
complex revealed that the characteristic sharp Nβ and Nγ reso-
nances (where assignment is Pt-NαNβNγ) at 230 ppm and
135 ppm were absent, consistent with loss of azido groups
(Fig. S1†). Whilst a characteristic azido absorbance
(2043 cm−1) was still observed for the mono substituted
complex trans-[Pt(C6H6N3O4)(N3)(py)2], this IR absorbance was
absent in the bis triazole.
We investigated the stability of the PtII triazole complexes
in a number of diﬀerent solvents; both the mono and bis tri-
azole complexes were unstable in d6-acetone, CDCl3, and d3-
Fig. 1 Commercially available alkynes investigated for their reactivity
towards trans,trans,trans-[Pt(N3)2(OH)2(py)2] (1): DMAD (2), DEACD
(3), N-[(1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethyloxycarbonyl]-1,8-
diamino-3,6-dioxaoctane and BCN (11) dibenzocyclooctyne-amine,
DBCO (12) were reactive, whereas phenylacetylene (4); 1,3-diethynyl-
benzene (5); phenylpropiolic acid (6); 3,4-diﬂuorophenylacetylene (7)
1-phenyl-2-propyn-1-ol (8); 3-butyn-2-one (9) and 4-phenyl-3-butyne-
2-one (10) were not.
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MeCN, slowly converting over time to new species, such that
NMR spectroscopic experiments needed to be run shortly after
sample preparation.
The PtIV complex 1 showed no reactivity stirring at 35 °C,
up to 7 d, with 5 eq. alkyne towards phenylacetylene (4);
1,3-diethynylbenzene (5); phenylpropiolic acid (6); 3,4-difluoro-
phenylacetylene (7) 1-phenyl-2-propyn-1-ol (8); 3-butyn-2-one
(9) and 4-phenyl-3-butyne-2-one (10). However, it was reactive
in diﬀerent solvents (including acetone, MeOH, EtOH, MeCN,
CHCl3 and THF) towards a number of alkynes: dimethyl
acetylenedicarboxylate DMAD (2), diethyl acetylenedicarboxy-
late DEACD (3), N-[(1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethyl-
oxycarbonyl]-1,8-diamino-3,6-dioxaoctane, BCN (11) and di-
benzocyclooctyne-amine DBCO (12) (Fig. 1).
Dimethyl acetylenedicarboxylate (DMAD, 2) and diethyl
acetylenedicarboxylate (DEACD, 3) products
Complex 1 reacted with 2 in MeOH to produce the cyclometal-
lated species 2a′ (1.1 eq. 2, 35 °C, 4 d) and 2b′ (5 eq. 2, 35 °C,
3 d), via intermediates 2a and 2b (Scheme 1).
The PtIV complex 1 reacted more slowly than its PtII pre-
cursor trans-[PtII(N3)2(py)2] with 2, taking approximately twice
as long under similar conditions to achieve conversion to pro-
ducts, as judged by 1H NMR spectroscopy. The initial complex
2a was detected by HPLC in trace amounts as the [2a + Na]+
adduct at 636.11 m/z (model 636.09 m/z) but was not isolated
in suﬃcient quantity for further analysis. Following isolation,
the cyclometallated derivative complex 2a′ was indefinitely
stable in D2O.
Both 13C and 1H NMR spectra of 2a′ were consistent with
attack of the axial hydroxide on the ester group and elimin-
ation of MeOH, with a sharp singlet resonance corresponding
to a single methyl group (3H) being observed at 3.78 ppm. The
13C NMR spectrum for 2a′ revealed inequivalent triazole
13C resonances at 138.4 ppm and 136.1 ppm. The 195Pt NMR
spectroscopic resonance in D2O was 91 ppm lower for 2a′
(873 ppm) than for 1 (964 ppm) indicating increased shielding
of the Pt centre.37 The 14N NMR spectrum of 2a′ (Fig. S2†) was
consistent with the proposed structure but aﬀorded little
additional structural information. The triazole 14N resonances
may, like Nα in coordinated azide (Pt–Nα–Nβ–Nγ) be exception-
ally broad, and/or may superimpose with either the Nβ
(229.0 ppm) or the Nγ/Npy (164.6 ppm) resonances, both of
which were considerably broader than for 1.46 IR spectroscopy
confirmed the presence of azide in the mono substituted pro-
ducts, in which the Pt–N3 group gave a sharp IR absorbance
ca. 2047 cm−1. Formation of bis substituted 2b′ resulted in
loss of the azido IR peak, compared with the mono substituted
2a′ (Fig. S3†).47 Complex 1 also reacted with DEACD (3) to
produce the corresponding cyclometallated mono (3a′) and bis
(3b′) species, at a slower rate than seen for the reaction with
DMAD (2).
MS/MS fragmentation studies of DMAD products 2a, 2a′, 2b
and 2b′ derivatives revealed that for complexes containing
non-cyclometallated triazoles (2a, 2b) these triazole ligands
dissociated intact (Fig. 2(a) and S4†). For the cyclometallated
complex 2a′ the triazole ligand dissociated by forming the
hydroxy species Fig. 2(b); MS/MS of the bis-substituted mono-
cyclometallated intermediate between 2b and 2b′ was also
investigated (Fig. S5†); this fragmented through loss of both
the cyclometallated and non-cyclometallated triazole ligands.
Transesterification
We observed transesterification between the DEACD triazole
ligand and the solvent when the cycloaddition reaction
between 1 and 3 was carried out in d4-MeOH, replacing the
remaining –OCH2CH3 group with –OCD3 (Scheme 2). This was
detected by ESI-MS as the [M + Na]+ adduct [Pt(N3)(py)2(OH)
(N3C3O4D3) + Na]
+ at 607.08 m/z (model 607.08 m/z) (Fig. S6†).
This species fragmented by MS/MS, showing loss of pyridine
and N3 to give the fragment [Pt(py)(OH)(N3C3O4D3) + Na]
+ at
486.04 m/z as well as further fragmentation through loss of the
intact cyclised deuterated ligand, giving the [Pt(OH)(py) + Na]+
ion at 314.00 m/z.
A similar transesterification was observed for DMAD deriva-
tives in d4-MeOH – this could be prevented by conducting reac-
tions and NMR spectroscopic experiments in appropriate
solvents.
Fig. 2 MS/MS of (a) 2a (614.11 m/z, [Pt(N3)(C6H6N3O4)(OH)2 (py)2 +
H]+, model 614.10 m/z) and (b) 2a’ ([Pt(N3)(C5H3N3O4)(OH) (py)2 + H]
+,
model 582.08 m/z) showing fragmentation through loss of intact ligand
for 2a and cyclometallated ligand for 2a’.
Scheme 2 Transesteriﬁcation of complexes 2a’ and 3a’ with alcoholic
solvent.
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Subsequent reactivity
In addition to cyclometallation and transesterification, the
complexes also displayed further solvent-dependent reactivity.
Although D2O and d4-MeOH solutions of 2a′ were stable (with
the exclusion of light) in CDCl3 a conversion from 2a′ to 2a″
was observed. Under extended reaction times (7 d) in MeOH
similar reactivity was observed; yellow 2a′ converted completely
to oﬀ-white 2a″ (insoluble in D2O). The
195Pt NMR resonance
of 2a″ in CDCl3 (764 ppm) was more shielded than for 2a′
(832 ppm) (ESI†). 14N NMR spectra of 2a′ and 2a″ were not
suﬃciently diagnostic (Fig. S2†). IR N3 azide absorbances
(2046 cm−1 and 2047 cm−1) were essentially the same in
strength and frequency for 2a′ and 2a″ and slightly higher
than for the parent complex 1 (2032 cm−1).47 Compound 2a″
had the same 1H NMR spectral integral ratios between pyridyl
and the OCH3 group as for 2a′, indicating that the ester group
was retained, but the pyridine Ho protons had become
deshielded.
Bis-substituted 2b′ was insoluble in D2O, MeOH and
d6-acetone but soluble in MeCN and CDCl3, giving rise to a
195Pt NMR resonance at 840 ppm (CDCl3). Complex 2b′ was
also unstable in CDCl3, converting over a few days to 2b″.
Complex 2b″ exhibited inequivalent methyl 1H NMR spectro-
scopic environments with 3H of the singlet corresponding to
the remaining OCH3 ester groups moving from 3.91 ppm to
3.88 ppm (ESI†). A new pyridyl environment was also observed,
with 2HPyortho protons becoming deshielded (moving from
8.85 ppm to 8.94 ppm) and corresponding new Hm and Hp
resonances overlapping with the existing resonances. Complex
2b″ was only sparingly soluble in CDCl3, precipitating from
solution over time. As with 2a″, the dominant ESI-MS species
were essentially unchanged during the transformation.
Although precedent suggests that a Pt–N1-bound triazole
may isomerise to a more thermodynamically stable N2-bound
complex32 we suggest that the steric requirements of the cyclo-
metallated ring in 2a′ and 2b′ makes N1 to N2 triazole
rearrangement unlikely. Further investigations are ongoing to
define the precise speciation of 2a″ and 2b″.
BCN products
Complex 1 reacted with BCN (11) in MeOH to give mono (11a)
and bis (11b) substituted products (Scheme 3). Products 11a
and 11b were soluble in both H2O and MeOH. The
13C NMR
spectra of 11a revealed the two alkyl carbons at 146.6 ppm and
142.4 ppm with characteristic 195Pt satellites and couplings of
27 Hz and 33 Hz, respectively (Fig. 3). This is consistent with
the observation that within Pt-pyridyl systems we commonly
observe 3JPtC couplings of this magnitude to Cmeta, and we typi-
cally do not observe platinum couplings to PyCortho or PyCpara.
For 11a, the inequivalence of these alkyl 13C resonances could
indicate N1 rather than N2 coordination of the triazole ring
(Fig. 3). For 11b resonances corresponding to the two alkyl
carbons were seen at 146.8 ppm and 142.1 ppm, indicating
similar coordination as seen for 11a, but for 11b the 195Pt
coupling on these resonances could not be resolved.
MS/MS experiments with [mono-(11a) + H]+ (796.2 m/z)
showed fragmentation through loss of the various charged
(N3
−, OH−, triazole etc.) and neutral (py) ligands; the triazole
ligand did not readily dissociate from the [M + H]+ species to
give the [M − triazole]+ fragment, but a stable fragment
[Pt(OH)(py)2]
+ was detected at 370.052 m/z, indicating it was
possible to remove the triazole ligand in association with other
ligands. MS/MS experiments with [bis-(11b) + H]+ (1120.5 m/z)
gave similar fragmentation to the mono species regarding
ready loss of H2O (1102.473 m/z) – a common pathway for Pt
dihydroxido species (e.g. 2a in Fig. 2). Complex [bis-(11b) + H]+
also showed loss of pyridine ligands to give [Pt(triazole)(tri-
azole − H) + py]+ at 1005.423 m/z and [Pt(triazole)(triazole − H)]+
at 926.384 m/z in which it is assumed one of the amine groups
of the BCN ligand provides stabilisation to the Pt centre; for
both 11a and 11b species the common [Pt(triazole − H)]+
fragment was detected around 560.17 m/z.
Dibenzocyclooctyne-amine (DBCO) products
Since DBCO 12 was insoluble in MeOH, complex 1 was reacted
with 12 in THF, producing both mono- (12a) and bis-(12b) sub-
stituted products (Scheme 3) which showed good agreement
Scheme 3 Reaction of 1 with 11 and 12.
Fig. 3 13C NMR (d4-MeOH) spectrum of 11a showing
195Pt satellites.
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with HRMS isotope models (Fig. S8†). Despite concerted
eﬀorts with a range of diﬀerent conditions, the compounds
showed poor chromatographic resolution by HPLC and only
small quantities of mono-(12a) were obtained, suﬃcient for
ESI-MS studies.
MS/MS experiments with [12a + H]+ (748.2 m/z) revealed
loss of neutral molecules (H2O, py) and the residual azido
ligand, and fragmentation was consistent with previous
MS/MS experiments of complex 1.37 As for the BCN derivatives,
the [M − triazole]+ species was not detected around 472 m/z,
indicating that the triazole was relatively tightly bound.
Rates of reaction and purification of products
Compared to PdII, PtII, RuII 32 and Au azido complexes, the
rates of cycloadditions of 1 with alkynes 2 3 and 11 were rela-
tively slow. Although they did proceed at room temperature,
gentle heating (35 °C) was typically employed. To proceed in
the absence of a catalyst, these cycloaddition reactions typi-
cally require an electron-rich azide and an electron-deficient
alkyne. Electron-withdrawing groups on the alkyne lower the
level of the LUMO, therefore promoting the reaction. The reac-
tions of 1 with alkynes 2, 11, and 12 resulted in a mixture of
mono and bis substituted products which in some cases then
further converted to additional rearrangement species. The
reactions with strained alkynes 11 and 12 proceeded signifi-
cantly faster (within 24 h at 35 °C) than for the electron
deficient alkyne 2 and there was no evidence of decomposition
to Pt(0) or cyclometallation. Mono triazole adducts were typi-
cally pale yellow, with bis triazole adducts oﬀ-white. This was
consistent with the UV-vis and IR data, and partial or total loss
of the azido group. Attempts to isolate complexes in high
purity using standard techniques were aided by mass-directed
preparative HPLC. A range of HPLC columns under neutral
(and basic – where compatible) conditions were investigated:
Atlantis, Hypersil, Sunfire and X-bridge OBD. The best purifi-
cation results for the complexes were obtained using mass-
directed purification on a Waters X-Bridge OBD column,
eluting with H2O + 0.1% NH4OH (pH 9)/MeCN + 0.1%
NH4OH.
We have previously reported DFT and TDDFT analysis of
complex 1; the absorbance in the UV-vis region is dominated
by 1LMCT (N3 → Pt) and mixed
1LMCT/3IL (OH → Pt, N3;
IL = interligand) transitions.37 UV-vis spectroscopy of the click
products were consistent with partial (mono) and complete
loss (bis) of the azido absorbances, compared to the starting
complex 1 (Fig. S7†) and resulted in a reduced absorption ca.
300 nm.
Experimental
General procedures
Materials. K2[PtCl4] was purchased from Precious Metals
Online. HPLC-grade solvents and Millipore filtered H2O were
used for the preparation and purification of compounds by
HPLC. All other reagents were purchased from Sigma-Aldrich
and used as received. (IM) indicates use of a nylon syringe
filter (pore size 0.2 μM). All manipulations were carried out
under reduced lighting and solutions were prepared stored
and handled with minimal exposure to light. NMR spectro-
scopy. Due to the potential photosensitivity of the compounds,
amberised NMR spectroscopy tubes (Goss Scientific) were
used. 13C NMR: acquired on a Bruker AVII 500 MHz spectro-
meter equipped with a z-gradient triple resonance inverse
1H/19F(13C) TXI probe and referenced internally to residual
solvent where possible or externally to TMS in CDCl3. All other
NMR spectra were acquired on a Bruker AVIIIHD 500 MHz
(1H: 500.13 MHz), a Bruker AVIIIHD 400 nanobay, or a Bruker
AV111-600 spectrometer at 298 K and processed using Topspin
3.2. J values are quoted in Hz. All chemical shift (δ) values are
given in parts per million. 1H NMR: chemical shifts were refer-
enced to residual solvent. 195Pt NMR: chemical shifts were
externally referenced to K2PtCl6 in 1.5 mM HCl in D2O
(δ 0 ppm) using parameters as previously described: for
spectra of PtIV species directly bonded to quadrupolar 14N,
typical parameters used were d1 = 0 s, TD 2k, DE 10 μs, 256k
scans.37 Data were processed with a LB of 50 Hz. 14N NMR:
chemical shifts were externally referenced to [14N]NH4Cl
(1.5 M) in 1 M HCl with a D2O coaxial insert and processed
with a qfil baseline correction. Mass spectrometry: low resolu-
tion ESI-MS: obtained with a Waters Micromass LCT Premier
XE spectrometer. HRMS: obtained with a Thermofisher
Exactive Plus with a Waters Acuity UPLC system. MS/MS experi-
ments: were performed on an Acuity UPLC in flow injection
analysis mode, equipped with a Waters Xevo G25 QTOF. All MS
data were processed using MassLynx 4.0. HPLC: were per-
formed with a Waters Autopurification system, equipped with
a Waters X-Bridge OBD semi-prep column (5 µm, 19 mm ×
50 mm), with an injection loop of 1 ml, eluting with H2O +
0.1% NH4OH (pH 9)/MeCN + 0.1% NH4OH. The crude
samples (in H2O/MeCN) were filtered (nylon, 0.2 µm) and
injected in 750 µL aliquots, with mass-directed purification
with an ACQUITY QDa performance mass spectrometer.
UV-visible absorption spectra were acquired with a T60U
Spectrometer PG Instruments Ltd using UVWin Software or
the Waters HPLC. Elemental microanalyses were performed by
Stephen Boyer at the London Metropolitan University.
Materials and methods
Synthetic procedures
The PtII complex trans-[PtII(N3)2(py)2] and 1 were prepared in
two steps from K2PtCl4, via trans-[Pt
IICl2(py)2]. H2O2 oxidation
of trans-[PtIV(N3)2(py)2] gave trans,trans,trans-[Pt
IV(N3)2(OH)2(py)2
(1) which was purified by HPLC before use. Analytical data was
consistent with previous reports.37 UV-Vis spectra and data con-
cerning reactivity of trans-[PtII(N3)2(py)2] are given in the ESI.†
Caution! No problems were encountered during this work,
however heavy metal azides are known to be shock sensitive
detonators, therefore it is essential that platinum azides
compound are handled with care.
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2018 Dalton Trans., 2018, 47, 10553–10560 | 10557
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Fe
br
ua
ry
 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
/1
6/
20
19
 1
1:
28
:2
3 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
PtIV complexes
Cycloadditions with DMAD (2)
Cyclometallated trans,trans,trans-[Pt(N3)(C5H3N3O4)(OH)(py)2]
(2a′). DMAD (2, 14.3 μl, 0.117 mmol) in MeOH (2 ml) was
added to 1 (50 mg, 0.106 mmol) in MeOH (3 ml). The solution
was stirred at 35 °C for 4 d before being placed on ice. Product
2a′ was isolated as a yellow precipitate by filtration and rinsed
with cold H2O, MeOH and diethyl ether (29 mg, 0.05 mmol,
47%).
1H NMR (400 MHz, D2O) δ: 8.71 (d,
3J1H195Pt = 25,
3JHH = 6,
4H, Ho) 8.25 (t,
3JHH = 7, 2H, Hp), 7.76 (dd,
3JHH = 7,
3JHH = 7,
4H, Hm), 3.87 (s, 3H, OMe).
195Pt NMR (107 MHz, D2O) δ: 873 (PWHH 670 Hz).
14N NMR (29 MHz, D2O) δ: 288.6 (N2 gas), 229.0 (Nβ), 164.6
(broad, Nγ/py). Nα not seen.
13C NMR (126 MHz, D2O) δ: 166.6 (Cester), 161.5 (Cester),
148.9 (Cpyortho), 143.3 (Cpypara), 138.4 (Ctriazole), 136.1 (Ctriazole),
127.8 (3J 13C195Pt = 25, Cpymeta), 52.9 (Calkyl).
1H NMR (400 MHz, CDCl3) δ: 8.98 (d,
3J1H195Pt = 25,
3JHH = 6,
4H, Ho), 8.14 (t,
3JHH = 7, 2H, Hp), 7.72 (dd,
3JHH = 7,
3JHH = 7,
4H, Hm), 1.64 (br) (with peaks corresponding to 2a″ growing in
over time).
195Pt NMR (107 MHz, CDCl3) δ: 832 (with peak at 767 ppm
corresponding to 2a″ growing in over time).
ESI-MS (MeOH, M = trans,trans,trans-[Pt(N3)(C5H3N3O4)
(OH)(py)2]) m/z: 1185.12 ([2 M + Na]
+ calcd 1185.14); 1163.14
([2M + H]+ calcd 1163.15); 604.05 ([M + Na]+ calcd 604.06);
582.07 ([M + H]+ calcd 582.08).
HRMS (MeOH) m/z: 582.0808 ([M + H]+, C15H15N8O5Pt calcd
582.0766).
IR (solid) ν cm−1: 3465, 3108, 3074, 2046 (νasymN3), 1732,
1674, 1611, 1538, 1460, 1437, 1389, 1337, 1254, 1211, 1197,
1127, 1078, 1018, 810, 773, 690.
Elemental microanalysis: Calc. C15H14N8O5Pt (581.07 g mol
−1):
C, 30.99; H, 2.43; N, 19.27. Found: C, 31.15; H, 2.46; N, 19.10.
Bis cyclometallated bis trans-[Pt(C5H3N3O4)2(py)2] (2b′). DMAD
(65.2 μl, 0.53 mmol) in MeOH (2 ml) was added dropwise to
trans,trans,trans-[Pt(N3)2(OH)2(py)2] (50 mg, 0.11 mmol) in
MeOH (3 ml). The solution was stirred at 35 °C for 3 days, put
on ice and the resulting white compound 2b′ isolated by
filtration (15.5 mg, 0.02 mmol, 21%).
1H NMR (400 MHz, CDCl3) δ: 8.87 (d,
3J1H195Pt = 22,
3JHH =
6 Hz, 4H, Ho) 8.10 (t,
3J1H1H = 6, 2H, Hp) 7.62 (t,
3J1H1H = 6, 4H,
Hm) 3.91 (s, 6H, OMe).
195 Pt NMR (107 MHz, CDCl3) δ: 840.
13C NMR (125 MHz, CDCl3) δ: 162.7 (Cestercyclo), 160.2
(CesterOMe), 153.4, 149.4 (Co), 143.4 (Cp), 139.3 (Calkene), 132.7
(Calkene), 128.3 (Cm), 52.6 (Calkyl).
ESI-MS (MeOH) (M = trans-[Pt(C5H3N3O4)2(py)]) m/z:
1405.09 ([2 M + Na]+ calcd 1405.14); 1383.12 ([2 M + H]+ calcd
1383.15); 714.04 ([M + Na]+ calcd 714.06); 692.06 ([M + H]+
calcd 692.08).
HRMS (MeOH) m/z: 714.06298 ([M + Na]+ C20H16N8O8PtNa
calcd 714.0631). IR ν cm−1: 3112, 2051, 1732, 1613, 1541, 1486,
1462, 1436, 1330, 1235, 1169, 1062, 1019, 835, 812, 690.
Elemental microanalysis Calc. C20H16N8O8Pt (691.07 g mol
−1):
C, 34.73; H, 2.33; N, 16.21. Found: C, 34.65; H, 2.28; N, 16.14.
Cycloadditions with BCN (11). BCN (11, 25 mg, 0.077 mmol,
1 eq.) was added to 1 (40 mg, 0.085 mmol) in MeOH (5 ml)
and the reaction stirred for 16 h at 35 °C. The volume was
reduced to 1 ml by rotary evaporation, filtered and purified by
HPLC. Products 11a (796.2 m/z) and 11b (1119.5 m/z) and
unreacted 1 were isolated and the solvent removed by freeze-
drying.
Monosubstituted trans,trans,trans-[Pt(N3)(C17H28N5O4)(OH)2
(py)2] (11a). Isolated as a pale yellow solid (18 mg, 18%).
1H NMR (500 MHz, d4-MeOH) δ: 8.80 (dd,
3J1H195Pt = 27,
3JHH =
7, 4H, HPyortho), 8.22 (t,
3JHH = 7, 2H, HPypara), 7.72 (dd,
3JHH =
7, 3JHH = 7, 4H, HPymeta), 3.99 (d, 2H, CH2OC(O)NH), 3.64
(s, 4H), 3.54 (m, 4H), 3.30 (m, 2H, obscured by solvent), 3.00
(t, 1H), 2.90 (m, 1H), 2.82 (m, 2H), 2.68 (m, 1H), 2.31 (m, 1H),
2.17 (m, 1H), 1.42 (m, 1H), 1.32 (m, 1H), 1.13 (m, 1H,
CHCH2OC(O)NH), 1.04 (s, 1H), 0.81 (m, 2H, H3mring).
195Pt NMR (129 MHz, d4-MeOH) δ: 842.
13C NMR (126 MHz,
d4-MeOH) δ: 159.2 (CvO), 151.0 (CPyortho), 146.6 ( J
13
C195Pt = 27,
Calkquat), 143.4 (CPypara), 142.4 ( J
13
C195Pt = 33, Calkquat), 127.5 (t,
3J13C195Pt = 27, CPymeta), 72.9, 71.32, 71.27, 71.0, 63.7 (CH2OC(O)
NH), 41.9, 41.7, 26.5, 25.1, 24.2, 23.5, 22.0, 21.7, 19.3. ESI-MS
(MeOH) m/z (M = trans,trans,trans-[Pt(N3)(C17H28N5O4)
(OH)2(py)2]): 398.63 [M + 2H]
2+ calcd C27H42N10O6Pt:
398.64439, 796.25 ([M + H]+ calcd C27H41N10O6Pt: 796.2853),
819.26 ([M + Na]+ calcd C27H40N10NaO6Pt: 819.2629). HRMS
(MeOH) m/z: 796.284 ([M + H]+ calcd C27H41N10O6Pt: 796.285).
MS/MS (796.2) (d4-MeOH) m/z: 778.276 ([M − OH]+
C27H39N10O5Pt, calcd 778.273), 718.252 ([M + H − py]+
C22H36N9O6Pt, calcd 718.242), 657.224 ([M + H − N3, py, OH]+
C22H34N6O5Pt, calcd 657.227), 639.212 ([M − H2O2, N3, py]+,
C22H32N6O4Pt, calcd 639.211), 560.174 ([M − H2O2, N3, 2py,
H]+, C17H27N5O4Pt, calcd 560.172), 370.055 ([Pt(OH)(py)2]
+,
C10H11N2OPt calcd 370.055).
IR (MeOH-d4) cm
−1: 3361 (br), 2920, 2044 (νasymN3, strong),
1695, 1613, 1543, 1457, 1264, 1211, 1104, 1077, 1020, 769, 690.
Bis BCN (11b). Isolated as an oﬀ-white solid (10 mg, 12%).
1H NMR (500 MHz, d4-MeOH) δ: 8.52 (m,
3J1H195Pt = 27,
3JHH =
6, 4H, 4HPyortho), 8.20 (t,
3JHH = 7, 2H, HPypara), 7.65 (dd,
3JHH =
7, 3JHH = 7, 4H, HPymeta), 4.01 (m, 4H), 3.68 (m, 2H), 3.64 (m,
8H), 3.54 (m, 6H), 3.45 (m, 2H), 3.29 (m, 2H, obscured by
solvent), 3.03 (m, 2H), 2.93 (m, 2H), 2.83 (m, 2H), 2.73 (m, 2H),
2.42 (m, 2H), 2.30 (m, 2H), 2.19 (m, 2H), 1.41, 1.15, 1.07, 0.93,
0.79 (m, 12H). 195Pt NMR (129 MHz, d4-MeOH) δ: 782.
13C NMR (126 MHz, d4-MeOH) δ: 159.3 (CvO), 151.3
(CPyortho), 146.8 (m), 143.7, 142.1 (m), 127.8 (
3J13C195Pt = 27,
CPymeta),71.5(m), 71.3(m), 71.0(m), 69.2, 63.7 (m), 43.9, 41.7(m),
26.5(m), 25.1(m), 24.3(m), 23.7 (m), 22.0(m), 21.5(m), 19.4(m).
ESI-MS (MeOH) m/z (M = trans,trans,trans-[Pt (C17H28N5O4)2
(OH)2(py)2]): 560.74 ([M + 2H]
2+ C44H68N12O10PtH2 calcd
560.7468), 1120.48 ([M + H]+, C44H69N12O10Pt, calcd
1120.4902). HRMS (MeOH) m/z: 1120.4933 [M + H]+,
C44H69N12O10Pt, calcd 1120.4902.
MS/MS (1120.5) d4-MeOH m/z: 1102.472 ([M − OH]+,
C44H67N12O9Pt, calcd 1102.484), 1067.439, 1005.423
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([M − H2O2, py, H]+ C39H60N11O8Pt, calcd 1005.430), 926.383
([M − H2O2, 2py, H]+, C34H55N10O8Pt, calcd 926.384), 560.167
([M − triazole, H2O2, 2py, H]+, C17H27N5O4Pt, calcd 560.172).
IR (MeOH-d4) cm
−1: 3366, 2482, 2244, 2072, 1120, 973, 822.
Cycloadditions with DBCO (12). Dibenzocyclooctyne-amine
(12, 20 mg, 0.04 mmol) and 1 (45 mg, 0.04 mmol) were dis-
solved in THF (15 ml) and stirred at 35 °C for 16 h, giving a
yellow solution which was filtered, and the solvent removed
under reduced pressure. The solid was reconstituted in 2 ml of
50 : 50 MeCN : H2O and purified by HPLC.
Monosubstituted trans,trans,trans-[Pt(N3)(C18H16N5O)(py)2(OH)2]
DBCO complex 12a was isolated as a yellow solid by HPLC
(4 mg, 7% yield).
ESI-MS (MeOH) m/z: (M = trans,trans,trans-[Pt(N3)
(C18H16N5O)(py)2(OH)2]): 748.18 ([M + H]
+, C28H29N10O3Pt
calcd 748.21), 770.13 ([M + Na]+ C28H28N10O3PtNa calcd 770.19
m/z). HRMS (MeOH) m/z: 748.2067 ([M + H]+, C28H29N10O3Pt
calcd 748.2066).
MS/MS (748.2) d4-MeOH m/z: 730.197 ([M − OH]+
C28H29N10O3Pt, calcd 730.197), 712.186, 688.183 ([M − N3,
H2O]
+, C28H27N7O2Pt calcd 688.187), 669.171 ([M − py + H]+
C23H24N9O3Pt, calcd 669.164), 609.146 ([M − N3, H2O, py]+,
C23H22N6O2Pt, calcd 609.148), 590.133 ([M − 2py + H]+
C18H19N8O3Pt, calcd 590.125). IR v cm
−1 (d4-MeOH): 3378(br),
2980, 2493(br), 2047 (νasymN3), 1637, 1613, 1479, 1457, 1212,
1117, 1076, 1019, 971, 765, 689.
Bis-substituted trans,trans,trans-[Pt(C18H16N5O)2(OH)2(py)2]
Complex 12b was isolated as an oﬀ-white solid by HPLC (3 mg,
4% yield).
ESI-MS (MeOH) m/z: (M = trans,trans,trans-
[Pt(C18H16N5O)2(OH)2 (py)2]): 1024.33 ([M + H]
+ C46H44N12O4PtH,
calcd 1024.33), 512.67 ([M + 2H]2+ C46H44N12O4PtH2, calcd
512.67). HRMS (MeOH) m/z: 1024.3335 ([M + H]+,
C46H44N12O4PtH calcd 1024.3285). IR v cm
−1 (d4-MeOH): 3346
(br), 2479(br), 2216, 2071, 1120, 972, 822.
Conclusions
The reactions of azido PtIV complex 1 with acetylenes 2, 3, 11
and 12 represent the first examples of PtIV azido cycloaddition
reactions. The reactions take place under mild conditions in
the absence of a catalyst, enabling modification of ligands
which are already coordinated to a metal centre, and providing
a route to monoazido complexes. Complex 1 did not show any
reactivity towards compounds 4–9; we suggest this is due to
the alkynes being insuﬃciently electron deficient for the
reaction to occur (Fig. 4).
For reactions of 1 with 2 and 3 there is evidence that Pt
cyclometallates with the new triazole ligand via the ester
group, displacing MeOH or EtOH respectively. This reactivity is
not observed for the PtII analogue trans-[Pt(N3)2(py)2]. Whilst
the cyclometallated complex 2a′ was stable in D2O, in other
solvents there is evidence for subsequent reactivity. In con-
trast, derivatives of complex 1 with cyclooctynes 11 and 12 did
not show any obvious subsequent reactivity following for-
mation of the triazole ligand.
Whilst use of electron withdrawing groups is an eﬀective
strategy to promote copper-free cycloadditions, for PtIV com-
plexes the proximity of these reactive groups to the Pt centre
can result in subsequent reactivity. Strain-promoted cyclo-
additions appear to be a promising alternative strategy, and we
are currently investigating appropriate cyclooctynes to further
investigate this chemistry.
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